Literature DB >> 28218937

Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco.

Emily Behar1, Christopher Rowe, Glenn-Milo Santos, Nina Santos, Phillip O Coffin.   

Abstract

BACKGROUND: Improving the safety of prescribed opioids in clinical settings is a national priority. While co-prescribing naloxone is increasingly recommended, there is little understanding of the optimal way to implement this practice.
METHODS: We developed and delivered an academic detailing intervention to 40 randomly selected opioid-prescribing primary care providers in San Francisco from February to May 2015. Process outcomes were tracked and included provider demographics, number and type of contact attempts, reason for refusal (if applicable), name of detailer, duration of intervention, topics covered, provider concerns, and follow-up plan. Outcome evaluation included changes in the rate of naloxone prescriptions 4 months before and after academic detailing by provider based on de-identified Medi-Cal claims data. Using a difference-in-differences approach, we developed a negative binomial regression model to compare changes in naloxone prescribing to Medi-Cal patients between providers that did and did not receive the intervention.
RESULTS: Eighty-three percent of 48 providers contacted accepted the intervention after a mean of 2.6 contacts. Detailing lasted a mean of 28 minutes (range 5-60 minutes) and most frequently covered indications for naloxone, examples of naloxone prescriptions, language to use with patients, and pharmacy outreach. Those who received the academic detailing had a significantly greater increase in naloxone prescriptions compared to those who did not receive the intervention (IRR=11.0, 95%CI=1.8-67.8, P=.010).
CONCLUSIONS: Academic detailing addressing opioid safety and naloxone prescribing was well-received by primary care providers and associated with an increase in naloxone prescriptions filled by Medi-Cal patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28218937

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  14 in total

1.  Identification of barriers to safe opioid prescribing in primary care: a qualitative analysis of field notes collected through academic detailing.

Authors:  Christopher D Saffore; Sarette T Tilton; Stephanie Y Crawford; Michael A Fischer; Todd A Lee; A Simon Pickard; Lisa K Sharp
Journal:  Br J Gen Pract       Date:  2020-07-30       Impact factor: 5.386

2.  Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.

Authors:  Bradley D Stein; Christopher M Jones; Rosanna Smart; Flora Sheng; Mark Sorbero
Journal:  Drug Alcohol Depend       Date:  2021-02-03       Impact factor: 4.492

Review 3.  Naloxone Academic Detailing: Role of Community Outreach Teaching.

Authors:  Alaa Abd-Elsayed; Christi Ann Albert; Matt Fischer; Brooke Anderson
Journal:  Curr Pain Headache Rep       Date:  2018-08-27

4.  Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.

Authors:  Robin A Pollini; Susannah Slocum; Jenny E Ozga; Rebecca Joyce; Ziming Xuan; Traci C Green; Alexander Y Walley
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19

5.  Naloxone dispensing among the commercially insured population in the United States from 2015 to 2018.

Authors:  Christopher Dunphy; Kun Zhang; Gery P Guy; Christopher M Jones
Journal:  Prev Med       Date:  2021-09-29       Impact factor: 4.637

6.  Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.

Authors:  Emily Behar; Rita Bagnulo; Phillip O Coffin
Journal:  Prev Med       Date:  2018-06-15       Impact factor: 4.018

7.  Academic detailing increases prescription drug monitoring program use among primary care practices.

Authors:  Sarah J Ball; Jenna A McCauley; Megan Pruitt; Jingwen Zhang; Justin Marsden; Kelly S Barth; Patrick D Mauldin; Mulugeta Gebregziabher; William P Moran
Journal:  J Am Pharm Assoc (2003)       Date:  2021-03-03

8.  Concurrent Naloxone Dispensing Among Individuals with High-Risk Opioid Prescriptions, USA, 2015-2019.

Authors:  Gery P Guy; Andrea E Strahan; Tamara Haegerich; Jan L Losby; Kathleen Ragan; Mary E Evans; Christopher M Jones
Journal:  J Gen Intern Med       Date:  2021-03-09       Impact factor: 6.473

9.  Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: a Retrospective Analysis.

Authors:  Bradley D Stein; Rosanna Smart; Christopher M Jones; Flora Sheng; David Powell; Mark Sorbero
Journal:  J Gen Intern Med       Date:  2021-02-17       Impact factor: 6.473

Review 10.  Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury.

Authors:  Joseph R Hsu; Hassan Mir; Meghan K Wally; Rachel B Seymour
Journal:  J Orthop Trauma       Date:  2019-05       Impact factor: 2.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.